AbbVie, Roche combo treatment meets main goal of leukemia trial

AbbVie Inc and Roche Holding AG said on Wednesday their immunotherapy delayed the progression of a type of blood and bone marrow cancer when used in combination with the Swiss drugmaker's cancer drug in a late-stage trial.


from Reuters: Health News https://ift.tt/2ADJhvU

Comentarii

Postări populare de pe acest blog

12 Sparkling Wine Cocktails for the Holidays

Take Your Fourth of July Barbecue Into the Future with These New Products